Metraipolis › archive › dc_282fdde40816
GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity — Europe PMC PMID:42231903
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42231903
- DOI
- 10.3389/fgstr.2026.1790420
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T04:48:14.777Z
- SHA-256 of the archived text
cfb0afbbcd7ceb18d011534c2ad0c0ffaf00b3569f69e2a256cf64d726a88e58- Stable URL of this page
https://metraipolis.com/documento/dc_282fdde40816
How to cite
GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity — Europe PMC PMID:42231903 — Europe PMC (en), https://europepmc.org/article/MED/42231903 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_282fdde40816 (Metraipolis archive dc_282fdde40816, sha256 cfb0afbbcd7ceb18d011534c2ad0c0ffaf00b3569f69e2a256cf64d726a88e58)
BibTeX
@misc{dc282fdde40816,
title = {GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity — Europe PMC PMID:42231903},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42231903},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_282fdde40816; sha256 cfb0afbbcd7ceb18d011534c2ad0c0ffaf00b3569f69e2a256cf64d726a88e58},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42231903. Agents can read the archived copy with the MCP tool read_document.